Patients with leukemia are eager to know their realistic life-expectancy to plan for the future. In this book you can find one of the newest prognostic factors that is likely to be superior to the other well-known prognosticators. CD49d is an easily investigated potent marker that can independently predict disease progression in chronic lymphocytic leukemia and might give a clue to reach a decision.